Influence of Variations in CCL3L1 and CCR5 on Tuberculosis in a Northwestern Colombian Population

Journal of Infectious Diseases

Volumn 203, Issue 11, 2011, Pages 1590-1594

  Mamtani, Manju ^a   Mummidi, Srinivas ^a   Ramsuran, Veron ^c,d   Pham, Minh Hieu ^a   Maldonado, Robert ^a   Begum, Kazi ^a   Valera, Maria Soledad ^a   Sanchez, Racquel ^a   Castiblanco, John ^a   Kulkarni, Hemant ^a   Ndung'u, Thumbi ^c,d   He, Weijing ^a   Anaya, Juan Manuel ^e,f   Ahuja, Sunil K ^a,b  

^a SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e Unidad de Biología Celular y Molecular   (Colombia)

^f UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

CCL3L1 CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR CCR5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; VIRUS RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CCR5 GENE; COLOMBIA; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENE DOSAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUBERCULOSIS;

ADULT; CASE-CONTROL STUDIES; CHEMOKINES, CC; COLOMBIA; FEMALE; GENE DOSAGE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, CCR5; TUBERCULOSIS;

EID: 79956196408     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir145     Document Type: Article

References (16)

1. Moller M, Hoal EG. Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis. Tuberculosis (Edinb) 2010; 90:71-83.
2. Camargo JF, Quinones MP, Mummidi S, et al. CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation. J Immunol 2009; 182:171-82.
3. Algood HM, Chan J, Flynn JL. Chemokines and tuberculosis. Cytokine Growth Factor Rev 2003; 14:467-77. (Pubitemid 37296020)
4. Pokkali S, Das SD. Augmented chemokine levels and chemokine receptor expression on immune cells during pulmonary tuberculosis. Hum Immunol 2009; 70:110-5.
5. Pokkali S, Das SD, Expression RL. of CXC and CC type of chemokines and its receptors in tuberculous and non-tuberculous effusions. Cytokine 2008; 41:307-14. (Pubitemid 351308157)
6. Qiu L, Huang D, Chen CY, et al. Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses. J Infect Dis 2008; 198:1514-9.
7. Lyadova IV, Tsiganov EN, Kapina MA, et al. In mice, tuberculosis progression is associated with intensive inflammatory response and the accumulation of gr-1 cells in the lungs. PLoS One 2010; 5:e10469.
8. Gonzalez E, Kulkarni H, Bolivar H, et al. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005; 307:1434-0.
9. Catano G, Chykarenko ZA, Mangano A, et al. Concordance of CCR5 genotypes that influence cell-mediated immunity and HIV disease progression rates. J Infect Dis 2011; 203:263-72.
10. Gomez LM, Anaya JM, Vilchez JR, et al. A polymorphism in the inducible nitric oxide synthase gene is associated with tuberculosis. Tuberculosis (Edinb) 2007; 87:288-94.
11. Gonzalez E, Bamshad M, Sato N, et al. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci U S A 1999; 96:12004-9. (Pubitemid 29502848)
12. Mummidi S, Bamshad M, Ahuja SS, et al. Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA: potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus. J Biol Chem 2000; 275:18946-61. (Pubitemid 30422860)
13. Kostrikis LG, Neumann AU, Thomson B, et al. A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. J Virol 1999; 73:10264-71.
14. Malhotra R, Hu L, Song W, et al. Association of chemokine receptor gene (CCR2-CCR5) haplotypes with acquisition and control of HIV-1 infection in Zambians. Retrovirology 2011; 8:22.
15. Tang J, Wilson CM, Schaen M, Myracle A, Douglas SD, Kaslow RA. CCR2 and CCR5 genotypes in HIV type 1-infected adolescents: limited contributions to variability in plasma HIV type 1 RNA concentration in the absence of antiretroviral therapy. AIDS Res Hum Retroviruses 2002; 18:403-12. (Pubitemid 34493905)
16. John GC, Bird T, Overbaugh J, et al. CCR5 promoter polymorphisms in a Kenyan perinatal human immunodeficiency virus type 1 cohort: association with increased 2-year maternal mortality. J Infect Dis 2001; 184:89-92. (Pubitemid 32568505)